- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular mechanisms in multiple myeloma drug resistance
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PATHOLOGY
Volume 69, Issue 2, Pages 97-101
Publisher
BMJ
Online
2015-11-24
DOI
10.1136/jclinpath-2015-203414
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MYC Protein Expression Is Detected in Plasma Cell Myeloma but Not in Monoclonal Gammopathy of Undetermined Significance (MGUS)
- (2014) Ruobing Xiao et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Ganetespib, a Novel Hsp90 Inhibitor in Patients With KRAS Mutated and Wild Type, Refractory Metastatic Colorectal Cancer
- (2014) Andrea Cercek et al. Clinical Colorectal Cancer
- Biology and Treatment of Myeloma
- (2014) Annamaria Brioli et al. Clinical Lymphoma Myeloma & Leukemia
- VER-155008, a small molecule inhibitor of HSP70 with potent anti-cancer activity on lung cancer cell lines
- (2014) Wei Wen et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies
- (2014) S. Caltagirone et al. HAEMATOLOGICA
- Regulated protein turnover: snapshots of the proteasome in action
- (2014) Sucharita Bhattacharyya et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases
- (2014) Ningning Liu et al. Scientific Reports
- A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance
- (2013) Z. Tian et al. BLOOD
- Multiple myeloma Leu167Ile (c.499C>A) mutation preventsXBP1mRNA splicing
- (2013) Shin Yee Hong et al. BRITISH JOURNAL OF HAEMATOLOGY
- Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma
- (2013) Chungyee Leung-Hagesteijn et al. CANCER CELL
- Proapoptotic effects of the novel proteasome inhibitor b-AP15 on multiple myeloma cells and natural killer cells
- (2013) Xiaoli Feng et al. EXPERIMENTAL HEMATOLOGY
- The PI3K/Akt signaling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival in multiple myeloma
- (2013) M. Chatterjee et al. HAEMATOLOGICA
- Unfolded Protein Response Signaling and Metabolic Diseases
- (2013) Jaemin Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Understanding the interplay between the proteasome pathway and autophagy in response to dual PI3K/mTOR inhibition in myeloma cells is essential for their effective clinical application
- (2013) L I Aronson et al. LEUKEMIA
- Unfolded protein response to autophagy as a promising druggable target for anticancer therapy
- (2012) Dong Hoon Suh et al. Annals of the New York Academy of Sciences
- Sorafenib Has Potent Antitumor Activity against Multiple Myeloma In Vitro, Ex Vivo, and In Vivo in the 5T33MM Mouse Model
- (2012) P. Kharaziha et al. CANCER RESEARCH
- Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition
- (2012) Mikko Taipale et al. CELL
- New Proteasome Inhibitors in Myeloma
- (2012) Panisinee Lawasut et al. Current Hematologic Malignancy Reports
- A review of the mammalian unfolded protein response
- (2011) Anirikh Chakrabarti et al. BIOTECHNOLOGY AND BIOENGINEERING
- MEK and MAF in myeloma therapy
- (2011) R. Popovic et al. BLOOD
- Microautophagy: lesser-known self-eating
- (2011) Wen-wen Li et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1
- (2011) S. C. W. Ling et al. HAEMATOLOGICA
- Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma
- (2011) W-J Chng et al. LEUKEMIA
- Targeting HSP 90 Induces Apoptosis and Inhibits Critical Survival and Proliferation Pathways in Multiple Myeloma
- (2011) T. Khong et al. MOLECULAR CANCER THERAPEUTICS
- The Role of Autophagy in Cancer: Therapeutic Implications
- (2011) Z. J. Yang et al. MOLECULAR CANCER THERAPEUTICS
- The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
- (2011) P. Walter et al. SCIENCE
- Many Multiple Myelomas: Making More of the Molecular Mayhem
- (2011) M. Chesi et al. Hematology-American Society of Hematology Education Program
- A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value
- (2010) B. A. Walker et al. BLOOD
- Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myeloma
- (2010) E L Davenport et al. LEUKEMIA
- Protein quality control in the ER: The recognition of misfolded proteins
- (2010) Pekka Määttänen et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma
- (2008) T Stühmer et al. LEUKEMIA
- The Chaperone-Mediated Autophagy Receptor Organizes in Dynamic Protein Complexes at the Lysosomal Membrane
- (2008) U. Bandyopadhyay et al. MOLECULAR AND CELLULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started